Verapamil Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 70518-0605

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 70518-0605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Verapamil HCI Extended-Release is a prescription medication indicated for various medical conditions. The drug comes in the form of extended-release tablets. Its NDC number is 70518-0605-00, and it is manufactured by Glenmark in Mahwah, NJ, USA. The drug should be stored at 20-26°C (63-77°F), and children should not have direct access to it. The drug comes with package instructions, and the repackaging of the medication is done by RemedyRepack Inc. in Indiana, PA.*

FDA Label Image

Structure

FDA Label Image

Verapamil HCl 180mg 70518 0605 01

Verapamil HCI is an extended-release medication that is only available through a prescription. It is manufactured by Glenmark in Mahwah, NJ and has an NDC number of 70518-0605-01. The lot number and expiration date can be found on the packaging. This medication should be stored between 20-26°C (63-77°F), but excursions to 15-30°C (59-86°F) are permitted. The package insert should be consulted for directions on how to properly use this medication. Repackaging of this medication was done by RemedyRepack Inc. located in Indiana, PA. It is important to keep all medication out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.